Kemwell Biopharma

Kemwell provides customized product development and manufacturing solutions to pharmaceutical and biopharmaceutical organizations worldwide. As a 100% contract services provider, the company services over 100 global bio/pharmaceutical companies, including 7 of the top 10 Big Pharma. Kemwell employs 1200 people, has 10 production facilities worldwide and supplies to 80 countries globally. For over 30 years, Kemwell has been pushing our boundaries to keep our customers competitive by our commitment to quality, respecting IP rights and working collaboratively with our customers. In 2013, Kemwell acquired Cirrus Pharmaceuticals, Inc (www.cirruspharm.com) contract product development company assisting biotechnology and pharmaceutical companies with dosage form development projects. Cirrus works with start-up, mid-size and multinational companies to provide a broad array of R&D services including physical and chemical characterization, formulation development, stability testing, container/closure selection, process development, as well as scale-up and technical transfer to manufacturing. Cirrus is proud to offer the world-class services of our scientific talent with expertise in the areas of inhaled, oral, topical, transdermal and parenteral product development.